688513 苑东生物
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)4.42410.0908.9888.97710.410
总资产报酬率 ROA (%)3.4057.8937.0627.1208.511
投入资产回报率 ROIC (%)4.0599.3478.2248.2479.946

边际利润分析
销售毛利率 (%)76.36275.25074.92580.01383.255
营业利润率 (%)20.15623.63218.66921.63922.266
息税前利润/营业总收入 (%)20.43821.75117.65320.63221.507
净利润/营业总收入 (%)17.01420.54817.65020.28221.061

收益指标分析
经营活动净收益/利润总额(%)66.30969.85674.37068.39065.414
价值变动净收益/利润总额(%)9.74018.7339.80410.54310.627
营业外收支净额/利润总额(%)1.066-4.9990.241-0.0400.519

偿债能力分析
流动比率 (X)3.2483.4463.2342.8483.228
速动比率 (X)2.8753.0772.9162.6052.962
资产负债率 (%)20.98319.98220.65222.21118.992
带息债务/全部投入资本 (%)5.0824.6724.1498.9493.878
股东权益/带息债务 (%)1,801.7131,967.6412,252.0251,001.0032,435.087
股东权益/负债合计 (%)365.554386.457384.207350.236426.547
利息保障倍数 (X)315.048-28.781-16.641-20.659-24.583

营运能力分析
应收账款周转天数 (天)47.62448.50339.69341.42938.348
存货周转天数 (天)275.459228.768186.713243.347224.584